CTSO — CYTOSORBENTS CORP

Ownership history in Compound Planning, Inc.  ·  6 quarters on record

This page tracks every 13F SEC filing in which Compound Planning, Inc. reported a position in CYTOSORBENTS CORP (CTSO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 27,443 — 0% 0.00% $18K $0.64
2025 Q3 UNCHANGED 27,443 — 0% 0.00% $26K $0.93
2025 Q2 REDUCED 27,443 -200 -0.7% 0.00% $35K $1.28
2025 Q1 ADDED 27,643 +200 +0.7% 0.00% $28K $1.00
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CTSO price (monthly, adj. close)

Other funds also holding CTSO

As of 2025 Q4 — sorted by position size

CM Management, LLC 3Y 0.8% AVENIR CORP 3Y 7Y 0.36% Skylands Capital, LLC 3Y 7Y 0.16% Sargent Investment Group, LLC 3Y 7Y 0.05% Key Client Fiduciary Advisors, LLC 3Y 0.02% Seelaus Asset Management LLC 3Y 7Y 0.01% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.01% NWF Advisory Services Inc. 0.01% Pathstone Holdings, LLC 0.0% Neuberger Berman Group LLC 3Y 7Y 0.0%
← Back to Compound Planning, Inc. Holdings